Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Brief Communication: Combination of an MIP3α-Antigen Fusion Therapeutic DNA Vaccine With Treatments of IFNα and 5-Aza-2'Deoxycytidine Enhances Activated Effector CD8+ T Cells Expressing CD11c in the B16F10 Melanoma Model.
Fessler K, Zhang J, Sandhu AK, Hui Y, Kapoor AR, Ayeh SK, Karanika S, Karakousis PC, Markham RB, Gordy JT. Fessler K, et al. Among authors: markham rb. J Immunother. 2025 Jan 1;48(1):1-5. doi: 10.1097/CJI.0000000000000542. Epub 2024 Oct 14. J Immunother. 2025. PMID: 39397434
Therapeutic DNA Vaccine Targeting Mycobacterium tuberculosis Persisters Shortens Curative Tuberculosis Treatment.
Karanika S, Wang T, Yilma A, Castillo JR, Gordy JT, Bailey H, Quijada D, Fessler K, Tasneen R, Rouse Salcido EM, Harris HT, Bates RE, Ton H, Meza J, Li Y, Taylor AD, Zheng JJ, Zhang J, Peske JD, Karantanos T, Maxwell AR, Nuermberger E, Markham RB, Karakousis PC. Karanika S, et al. Among authors: markham rb. bioRxiv [Preprint]. 2024 Sep 7:2024.09.03.611055. doi: 10.1101/2024.09.03.611055. bioRxiv. 2024. PMID: 39282461 Free PMC article. Preprint.
Immature dendritic cell-targeting mRNA vaccine expressing PfCSP enhances protective immune responses against Plasmodium liver infection.
Yanik S, Venkatesh V, Gordy JT, Gabriel-Alameh M, Meza J, Li Y, Glass E, Flores-Garcia Y, Tam Y, Chaiyawong N, Sarkar D, Weissman D, Markham R, Srinivasan P. Yanik S, et al. Among authors: markham r. Res Sq [Preprint]. 2024 Jul 9:rs.3.rs-4656309. doi: 10.21203/rs.3.rs-4656309/v1. Res Sq. 2024. PMID: 39041038 Free PMC article. Preprint.
A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses.
Gordy JT, Hui Y, Schill C, Wang T, Chen F, Fessler K, Meza J, Li Y, Taylor AD, Bates RE, Karakousis PC, Pekosz A, Sachithanandham J, Li M, Karanika S, Markham RB. Gordy JT, et al. Among authors: markham rb. Front Immunol. 2024 Feb 2;15:1292059. doi: 10.3389/fimmu.2024.1292059. eCollection 2024. Front Immunol. 2024. PMID: 38370404 Free PMC article.
Combination of a MIP3α-antigen fusion therapeutic DNA vaccine with treatments of IFNα and 5-Aza-2'Deoxycytidine enhances activated effector CD8+ T cells expressing CD11c in the B16F10 melanoma model.
Fessler K, Zhang J, Sandhu AK, Hui Y, Kapoor AR, Ayeh SK, Karanika S, Karakousis PC, Markham RB, Gordy JT. Fessler K, et al. Among authors: markham rb. Res Sq [Preprint]. 2024 Aug 20:rs.3.rs-3243336. doi: 10.21203/rs.3.rs-3243336/v2. Res Sq. 2024. Update in: J Immunother. 2025 Jan 1;48(1):1-5. doi: 10.1097/CJI.0000000000000542 PMID: 37645859 Free PMC article. Updated. Preprint.
Real-time virtual supports improving health equity and access in British Columbia.
Novak Lauscher H, Stewart K, Markham R, Pawlovich J, Mah J, Hunt M, Williams K, Christenson J, Graham S, Bepple K, Pritchard E, Rabeneck J, Yang M, Ho K. Novak Lauscher H, et al. Among authors: markham r. Healthc Manage Forum. 2023 Sep;36(5):285-292. doi: 10.1177/08404704231183177. Epub 2023 Jun 20. Healthc Manage Forum. 2023. PMID: 37339260 Free PMC article.
394 results